The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKORN INC | NOTE 3.500% 6/0 | 009728AB2 | 20,652 | 4,991,000 | PRN | SOLE | 4,991,000 | 0 | 0 | ||
| CADENCE DESIGN SYSTEM INC | NOTE 2.625% 6/0 | 127387AJ7 | 243,002 | 106,332,000 | PRN | SOLE | 106,332,000 | 0 | 0 | ||
| CARROLS RESTAURANT GROUP INC | COM | 14574X104 | 356 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | NOTE 1.625% 5/0 | 375558AP8 | 68,345 | 14,631,000 | PRN | SOLE | 14,631,000 | 0 | 0 | ||
| SBA COMMUNICATIONS CORP | NOTE 4.000%10/0 | 78388JAM8 | 977,174 | 270,003,000 | PRN | SOLE | 270,003,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 9,946 | 1,144,514 | SH | SOLE | 1,144,514 | 0 | 0 | ||